Statements (19)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
antiviral drug |
| gptkbp:ATCCode |
none
|
| gptkbp:CASNumber |
958002-33-0
|
| gptkbp:chemicalFormula |
C36H41N5O5
|
| gptkbp:developedBy |
gptkb:Bristol-Myers_Squibb
|
| gptkbp:hasSMILES |
CC1=CC2=C(C=C1)C(=O)N(C2=O)C3CCN(CC3)C(=O)C4=CC=CC=C4N5CCN(CC5)C(=O)C6=CC=CC=C6O
|
| https://www.w3.org/2000/01/rdf-schema#label |
beclabuvir
|
| gptkbp:mechanismOfAction |
gptkb:NS5B_polymerase_inhibitor
|
| gptkbp:molecularWeight |
623.75 g/mol
|
| gptkbp:PubChem_CID |
CHEMBL2105756
46216323 |
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:status |
investigational drug
|
| gptkbp:synonym |
BMS-791325
|
| gptkbp:UNII |
6Z5B6D8H8V
|
| gptkbp:usedFor |
treatment of hepatitis C
|
| gptkbp:bfsParent |
gptkb:NS5B_polymerase_inhibitor
|
| gptkbp:bfsLayer |
7
|